ASTH vs. WSC, LIF, QBTS, SEZL, STNE, FTDR, HRI, HNGE, GLOB, and CARG
Should you be buying Astrana Health stock or one of its competitors? The main competitors of Astrana Health include WillScot (WSC), Life360 (LIF), D-Wave Quantum (QBTS), Sezzle (SEZL), StoneCo (STNE), Frontdoor (FTDR), Herc (HRI), Hinge Health (HNGE), Globant (GLOB), and CarGurus (CARG). These companies are all part of the "business services" industry.
Astrana Health vs. Its Competitors
Astrana Health (NASDAQ:ASTH) and WillScot (NASDAQ:WSC) are both business services companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk and dividends.
In the previous week, WillScot had 3 more articles in the media than Astrana Health. MarketBeat recorded 8 mentions for WillScot and 5 mentions for Astrana Health. WillScot's average media sentiment score of 1.24 beat Astrana Health's score of 0.94 indicating that WillScot is being referred to more favorably in the news media.
Astrana Health currently has a consensus price target of $53.29, suggesting a potential upside of 110.78%. WillScot has a consensus price target of $40.63, suggesting a potential upside of 36.97%. Given Astrana Health's stronger consensus rating and higher possible upside, research analysts clearly believe Astrana Health is more favorable than WillScot.
Astrana Health has higher earnings, but lower revenue than WillScot. Astrana Health is trading at a lower price-to-earnings ratio than WillScot, indicating that it is currently the more affordable of the two stocks.
52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 95.8% of WillScot shares are owned by institutional investors. 20.0% of Astrana Health shares are owned by insiders. Comparatively, 3.1% of WillScot shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Astrana Health has a net margin of 1.56% compared to WillScot's net margin of 0.63%. WillScot's return on equity of 26.28% beat Astrana Health's return on equity.
Astrana Health has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Comparatively, WillScot has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500.
Summary
WillScot beats Astrana Health on 9 of the 16 factors compared between the two stocks.
Get Astrana Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ASTH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ASTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Astrana Health Competitors List
Related Companies and Tools
This page (NASDAQ:ASTH) was last updated on 7/17/2025 by MarketBeat.com Staff